Title : Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.

Pub. Date : 2015 Jun

PMID : 26297284






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia. Decitabine fms related receptor tyrosine kinase 3 Homo sapiens
2 PATIENTS AND METHODS: Here we describe our preclinical and clinical experience with the combination of the DNA hypomethylating agent, decitabine and sorafenib for the treatment of FLT-3 ITD-mutant AML. Decitabine fms related receptor tyrosine kinase 3 Homo sapiens